期刊文献+

Composite hepatocellular and hemangiosarcomatous tumor: The prognosis is determined by the sarcomatous component

下载PDF
导出
摘要 Nowadays, mixed liver tumors are more frequently diagnosed due to better imaging, advanced immunohistochemistry (IHC) staining techniques and better knowledge of hepatic tumorigene- sis [1–3] . Such tumors represent a mosaic of components with dis- tinct histogenesis and carcinogenic pathways. As their occurrence in the liver is very rare, their behavior and natural history are difficult to determine, and their management remains empirical. An uncommon case of a composite tumor harboring hepatocellular carcinoma (HCC) and hepatic hemangiosarcoma (HHS) components in a liver transplant (LT) recipient is reported herein.
出处 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS CSCD 2020年第2期184-186,共3页 国际肝胆胰疾病杂志(英文版)
  • 相关文献

参考文献1

二级参考文献3

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部